SynVivo Inc.

SynVivo Inc. is a biotechnology company that develops 3D tissue and organ-on-a-chip models designed to provide a biologically realistic microenvironment for life sciences research. The company’s platform utilizes microfluidic chips to recreate complex in vivo microvasculature, including features such as physiological flow, shear stress, pressure gradients, and cellular interactions. This technology enables real-time visualization and quantitation of biological processes, offering a more predictive alternative to traditional static cell culture systems. The company also provides associated instruments and accessories to support these advanced microfluidic applications.

By accurately simulating human physiology, SynVivo’s technology helps researchers accelerate studies in areas such as drug discovery, drug delivery, toxicology, oncology, neuroscience, and inflammation. Their models, including specialized platforms like SynTumor, SynBBB, and SynRAM, allow for the investigation of cellular behaviors and interactions that are difficult to capture in conventional models. The company’s solutions are used in academic and pharmaceutical research, with applications supported by peer-reviewed publications and presentations at industry events. Headquartered in Huntsville, Alabama, SynVivo was founded in 2015 to advance human-relevant in vitro testing.